Doganieros' Pharmacy Inc is categorized under in Camden, NJ and active since 1945.
Doganieros' Pharmacy Inc was established in 1945, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a business, which does work in the B2C market, and is classified as a , under code number 4461100 by the NAICS.
If you are seeking more information, feel free to contact Robert Doganieros, Manager at the company’s single location by writing to 1552 Mount Ephraim Avenue, Camden, New Jersey NJ 08104 or by phoning (856) 966-4400. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Doganieros' Pharmacy Inc |
| Contact Person: | Robert Doganieros, Manager |
| Address: | 1552 Mount Ephraim Avenue, Camden, New Jersey 08104 |
| Phone Number: | (856) 966-4400 |
| Website Address: | camdenrealestate4sale.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 1945 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | |
| SIC Code: | 5912 |
| NAICS Code: | 4461100 |
| Share This Business: |
Doganieros' Pharmacy Inc was started in 1945 to provide professional under the SIC code 5912 and NAICS code 4461100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Robert Doganieros, Manager for inquiries that concern Doganieros' Pharmacy Inc by calling the company number (856) 966-4400, as your correspondence is most welcome. Additionally, the physical location of the single location of Doganieros' Pharmacy Inc can be found at the coordinates 39.92611,-75.10592 as well as the street address 1552 Mount Ephraim Avenue in Camden, New Jersey 08104.
For its online presence, you may visit Doganieros' Pharmacy Inc’s website at camdenrealestate4sale.com and engage with its social media outlets through on Twitter and on Facebook.